Skip to content

Acceptability, Practicality and Preliminary Indications of Efficacy of a Blended Individual Mindfulness Intervention for Patients with Persistent Depression

Jonathan Hamilton, Kate Brennan, Daniel Brown, Thorsten Barnhofer

Mindfulness July 1, 2025 DOI: 10.1007/s12671-025-02598-5 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Preregistered Qualitative Peer reviewed
Sample size 39
Population Patients with persistent depression
Intervention more frequent practices (15 min twice a day)
Duration 12-week intervention
Topics Depression Meditation
Registration NCT04576741
Key findings A blended individual mindfulness-based intervention with minimal therapist support led to large reductions in depression symptoms among completers, with 75% moving below the clinical threshold.

Abstract

Abstract Objectives Mindfulness training has been shown to be helpful in the treatment of depression. However, standard mindfulness-based interventions (MBIs) are still not widely available and sustaining a mindfulness practice can be difficult for patients with current depression. Alternative delivery formats may serve to address these problems. This study tested the acceptability, practicality and preliminary efficacy of a blended individual mindfulness-based intervention that supports patients in their practice individually and beyond the duration of standard mindfulness-based interventions.

Method: Thirty-nine patients with persistent depression were entered into the study and supported to practice with either standard length practices (30 min once a day) or shorter, more frequent practices (15 min twice a day) over 12 weeks with minimal therapist support (6 sessions of 30 min duration). Symptoms were assessed at the beginning, and after each third of the intervention. Engagement in practice was monitored throughout and qualitative interviews were conducted post-intervention. Data from 24 service users who waited for depression treatment were collected for benchmarking purposes.

Results: Of those randomised, 24 (62%) completed the intervention. Completers engaged in an average of 89% of formal practices and showed reductions in symptoms of high effect size, η p 2 = 0.66, 90% CI [0.54, 0.73], with 75% of completers moving to symptoms levels below the clinical threshold. Thematic analysis of feedback from completers indicated high acceptability but highlighted the need for longer therapist sessions.

Conclusions: Blended individual mindfulness-based interventions have promise for supporting depressed patients to engage in mindfulness practice and reduce symptoms while aligning well with current trends in service delivery. However, adjustments to the current intervention in line with patient suggestions, including more time for individual therapist sessions to bring them closer to the standard length of psychotherapy sessions, are needed to reduce drop-out and underlying practicality problems. Preregistration This study was pre-registered on ClinicalTrials.gov (ClinicalTrials.gov ID: NCT04576741).

Comparable studies

Other randomized controlled trials on depression, most cited first.

Study Year Design Participants
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Subjects with DSM-IV major depression (treatment resistant) 2006 Randomized, placebo-controlled, double-blind crossover study n = 18
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics